Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
May activate or repress transcription via interactions with sequence specific DNA-binding proteins. Additionally we are shipping MYBBP1A Kits (6) and MYBBP1A Proteins (3) and many more products for this protein.
Showing 10 out of 77 products:
Human Polyclonal MYBBP1A Primary Antibody for WB - ABIN1881560
Perrera, Colombo, Valsasina, Carpinelli, Troiani, Modugno, Gianellini, Cappella, Isacchi, Moll, Rusconi: Identification of Myb-binding protein 1A (MYBBP1A) as a novel substrate for aurora B kinase. in The Journal of biological chemistry 2010
Show all 5 Pubmed References
Human Polyclonal MYBBP1A Primary Antibody for ICC, IF - ABIN253189
Nahálková, Tomkinson: TPPII, MYBBP1A and CDK2 form a protein-protein interaction network. in Archives of biochemistry and biophysics 2014
Guinea Pig Polyclonal MYBBP1A Primary Antibody for IHC, WB - ABIN2780004
Fan, Rhee, St-Pierre, Handschin, Puigserver, Lin, Jäeger, Erdjument-Bromage, Tempst, Spiegelman: Suppression of mitochondrial respiration through recruitment of p160 myb binding protein to PGC-1alpha: modulation by p38 MAPK. in Genes & development 2004
Show all 2 Pubmed References
Mybbp1a is a novel negative regulator of Sirt7 (show SIRT7 Antibodies).
Data show that down-regulation of MYBBP1A decreases the growth rate of wild type mouse embryonic stem cells, embryo fibroblasts (MEFs) and of human HeLa cells, where it also promotes apoptosis.
Mybbp1a may play a dual role in the rRNA metabolism, potentially linking and coordinating ribosomal DNA transcription and pre-rRNA processing to allow for the efficient synthesis of ribosomes.
Myb-binding protein 1a was identified as a novel negative regulator of muscle-specific (show EIF3K Antibodies) gene expression and myoblast differentiation.
Myb (show MYB Antibodies)-binding protein p160 (show MSH6 Antibodies) is a novel target of the von Hippel-Lindau tumor suppressor.
Ipr1 (show SP110 Antibodies) might be involved in apoptosis pathway via MYBBP1A.
Myb-binding protein 1a augments AhR (show AHR Antibodies)-dependent gene expression
Mybbp1a is a nucleocytoplasmic shuttling protein involved in nuclear import and export via CRM1 (show XPO1 Antibodies)-dependent and -independent pathways.
These data show that p160 (show MSH6 Antibodies) is a novel regulator of Prep1-Pbx1 (show PBX1 Antibodies) transcriptional activity.
SRC-3 (show NCOA3 Antibodies) alone of the p160 (show MSH6 Antibodies) coactivators enhanced CAR transactivation in hepatic cells without PB treatment.
The results indicated that both the heterozygous genotype GC and homozygous genotype CC in rs3809849 in MYBBP1A had significant effects on the risk of pulmonary tuberculosis, and heterozygous genotype CT in rs9061 in SP110 (show SP110 Antibodies) also had similar effects.
We propose that the nucleolus functions as a stress sensor to modulate p53 (show TP53 Antibodies) protein levels and its acetylation status, determining cell fate between cell cycle arrest and apoptosis by regulating MYBBP1A translocation.
MYBBP1A(low)AKT (show AKT1 Antibodies)(Ser473)(high) staining pattern serves not only as a marker for the pre-senescent stage but also as an indicator of OPSCC patients at high risk for treatment failure.
TPPII (show Tpp2 Antibodies), MYBBP1A and CDK2 (show CDK2 Antibodies) form a protein-protein interaction network.
MYBBP1A functions to enhance p53 (show TP53 Antibodies) tetramerization that is necessary for p53 (show TP53 Antibodies) activation.
Regulators, including BCL11A (show BCL11A Antibodies), MYB (show MYB Antibodies), and KLF1 (show KLF1 Antibodies), hold great promise to develop targeted and more effective approaches for HbF induction.
MYBBP1A-p53 (show TP53 Antibodies) binding property can account for efficient p53 (show TP53 Antibodies)-activation by MYBBP1A under nucleolar stress. Our results support the idea that MYBBP1A plays catalytic roles in p53 (show TP53 Antibodies) acetylation and activation
Suggest that MYBBP1A is required for p53 (show TP53 Antibodies) activation during anoikis; therefore, it is involved in suppressing colony formation and the tumorigenesis of breast cancer cells.
May activate or repress transcription via interactions with sequence specific DNA-binding proteins. Repression may be mediated at least in part by histone deacetylase activity (HDAC activity).
MYB binding protein (P160) 1a
, MYB binding protein 1a
, myb-binding protein 1A-like
, myb-binding protein 1A
, myb-binding protein of 160 kDa
, nuclear protein P160
, MYB binding protein 1a
, PAR interacting protein
, PAR-interacting protein
, p53-activated protein-2
, myb-binding protein 1A-like protein